Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001019687-10-003204
Filing Date
2010-08-27
Accepted
2010-08-27 16:19:07
Documents
6
Period of Report
2010-10-21
Effectiveness Date
2010-08-27

Document Format Files

Seq Description Document Type Size
1 PEREGRINE PHARMACEUTICALS, INC. peregrine_def14a-043010.htm DEF 14A 994258
2 peregrine_logo.jpg GRAPHIC 13490
3 comparison_5yr.jpg GRAPHIC 42197
4 signature.jpg GRAPHIC 5398
5 exhibitb_graphic1.jpg GRAPHIC 214508
6 exhibitb_graphic2.jpg GRAPHIC 103616
  Complete submission text file 0001019687-10-003204.txt   1519131
Mailing Address 14282 FRANKLIN AVE TUSTIN CA 92780
Business Address 14282 FRANKLIN AVE TUSTIN CA 92780 7145086000
PEREGRINE PHARMACEUTICALS INC (Filer) CIK: 0000704562 (see all company filings)

EIN.: 953698422 | State of Incorp.: DE | Fiscal Year End: 0430
Type: DEF 14A | Act: 34 | File No.: 001-32839 | Film No.: 101044277
SIC: 2835 In Vitro & In Vivo Diagnostic Substances